Two technicians in white coats reviewing documentation on the manufacture of active ingredients (APIs) at the Ferrer chemical plant.

Business

Active pharmaceutical ingredients

We research, develop and market active pharmaceutical ingredients under the brand name Interquim.

The content of this section is corporate and industrial in nature and is aimed at customers, partners and stakeholders of the active pharmaceutical ingredients business.

 

At Ferrer, we have more than four decades of experience manufacturing and marketing active pharmaceutical ingredients (APIs) for the global industry. Our priority is to guarantee the highest quality at every stage of the process, complying with the most demanding international standards and Good Manufacturing Practices (GMP).

 

Sustainability is a fundamental pillar in our activity. We develop our processes under green chemistry criteria and are ISO 14001 certified, minimizing environmental impact and promoting safety in the work environment. Our facilities in Sant Cugat del Vallès, Barcelona, approved by the main regulatory agencies, reflect our commitment to industrial excellence and respect for the environment.

 

We understand that quality and sustainability are essential to building trust and long-term value. In this way, we contribute to our purpose of using the business to fight for social justice, always keeping in mind the health and care of the planet.

What do we offer our customers?

  • 1

    Extensive experience in global sanitary registration and support in regulatory processes for clients.

  • 2

    Support from the Intellectual Property team to accelerate time to market.

  • 3

    Extensive technical support in R+D, analytical development and studies for regulatory compliance.

  • 4

    In-house manufacturing in Barcelona with FDA, PMDA and EU approvals, among others.

API's Catalog

Active Ingredients in Interquim:

Roflumilast

Roflumilast is an active substance indicated in the treatment of chronic obstructive pulmonary disease (COPD).

Roflumilast

Treatment for COPD
CAS Nº:
162401-32-3
STATUS
Fully developed
BATCH SIZE
72 kg
SHELF LIFE
5 years
DMF/CEP AVAILABILITY
USDMF/ASMF
PHARMACOPOEIA
USP

Sterile paliperidone palmitate

Paliperidone palmitate is an active substance that acts as an antipsychotic.

Sterile paliperidone palmitate

Antipsychotic
CAS Nº:
199739-10-1
STATUS
Fully developed
BATCH SIZE
15-23 kg
SHELF LIFE
5 years
DMF/CEP AVAILABILITY
USDMF/ASMF/CN-DMF/DIFA/MF
PHARMACOPOEIA
No pharmacopoeia available

Sterile aripiprazole monohydrate

Aripiprazole monohydrate is an active substance that acts as an antipsychotic.

Sterile aripiprazole monohydrate

Antipsychotic
CAS Nº:
851220-85-4
STATUS
Fully developed
BATCH SIZE
17 kg
SHELF LIFE
5 years
DMF/CEP AVAILABILITY
USDMF
PHARMACOPOEIA
No pharmacopoeia available

Tapinarof

Tapinarof is an active ingredient for the treatment of psoriasis and atopic dermatitis.

Tapinarof

Psoriasis, atopic dermatitis
CAS Nº:
79338-84-4
STATUS
Fully developed
BATCH SIZE
20 kg
SHELF LIFE
5 years
DMF/CEP AVAILABILITY
USDMF
PHARMACOPOEIA
No pharmacopoeia available

Ferric carboxymaltose

Ferric carboxymaltose is an active substance indicated in the treatment of iron deficiency anemia.

Ferric carboxymaltose

Iron deficiency anemia
CAS Nº:
9007-72-1
STATUS
Fully developed
BATCH SIZE
70 kg
SHELF LIFE
5 years
DMF/CEP AVAILABILITY
USDMF/ASMF
PHARMACOPOEIA
No pharmacopoeia available

Rivastigmine

Rivastigmine is an active substance indicated in the treatment of dementia caused by Alzheimer's disease

Rivastigmine

Alzheimer's Dementia Treatment
CAS Nº:
123441-03-2
STATUS
Fully developed
BATCH SIZE
120 kg
SHELF LIFE
3 years
DMF/CEP AVAILABILITY
USDMF/CEP/ASMF/CADMF/J-MF/T-DMF/K-DMF, CN DMF
PHARMACOPOEIA
USP/Ph. Eur.

Aripiprazole lauroxyl

Aripiprazole lauroxyl is an active substance that acts as an antipsychotic.

Aripiprazole lauroxyl

Antipsychotic
CAS Nº:
1259305-29-7
STATUS
In development
BATCH SIZE
20 kg
SHELF LIFE
5 years
DMF/CEP AVAILABILITY
USDMF
PHARMACOPOEIA
No pharmacopoeia available

Lumateperone tosylate

Lumateperone tosylate is an active substance that acts as an antipsychotic.

Lumateperone tosylate

Antipsychotic
CAS Nº:
1187020-80-9
STATUS
In development
BATCH SIZE
20 kg
SHELF LIFE
5 years
DMF/CEP AVAILABILITY
USDMF
PHARMACOPOEIA
No pharmacopoeia available

Ready to develop extraordinary treatments together?

Last updated: July 2026